Search Results 451-460 of 17575 for Toxin

1. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

   Subjects should not have a planned botulism toxin or sympathectomy during their participation in the study. Subjects with gangrene or digital amputation ...

2. First aid for snakebites - Mayo Clinic News Network

   Some snakes, such as coral snakes, have toxins that cause neurological symptoms, such as skin tingling, difficulty speaking and weakness. Sometimes, a ...

3. Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia - Mayo Clinic

   Prior esophageal injection of botulinum toxin (Botox) within 6 months prior to randomization or more than 2 esophageal Botox injection procedures in their ...

4. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

   Radio- or toxin immunoconjugates =< 10 weeks; Radiation therapy =< 3 weeks; Or major surgery =< 2 weeks. Prior treatment with an anti-PD-1, anti-PD-L1, anti-PD ...

5. Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms - Mayo Clinic

   History of any esophageal/gastric/pyloric injection of botulinum toxin 17. Patients on daily opioid use or \>3 day/week use 18. Use of glucagon-like peptide ...

6. Vaginal discharge Causes - Mayo Clinic

   Yeast infections, bacterial vaginosis and menopause all can change vaginal discharge. These conditions can make you uncomfortable, but there are treatments ...

7. Deb Balzer | Mayo Clinic News Network - Page 46 of 73

   Tetanus is a serious infection that can be life-threatening and easily prevented with vaccination. It is caused by a toxin produced by spores of the bacteria, ...

8. A Study to Evaluate the Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

   Any botulinum toxin use within 3 months before the screening visit. Recorded diagnosis or evidence of major psychiatric diagnosis, significant cognitive ...

9. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

   Difficile toxin at screening; History of gastrointestinal surgery within 8 weeks of baseline; Primary Sclerosing Cholangitis; Any uncontrolled or clinically ...

10. A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea - Mayo Clinic

    Have received an investigational product containing monoclonal antibodies against toxin A or B within 180 days;; Had more than 2 episodes of CDAD within 90 ...